Endoscopic Retrograde Cholangiopancreatography Market Share and Trends Report 2025-2033 from stanley huds's blog

IMARC Group’s report titled “Endoscopic Retrograde Cholangiopancreatography Market Report by Product (Endoscope, Endotherapy Devices, Visualization Systems, Energy Devices, and Others), Procedure (Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting, Pancreatic Duct Dilatation), End User (Hospitals and Clinics, Ambulatory Surgery Centers, and Others), and Region 2025-2033​”. offers a comprehensive analysis of the industry, which comprises insights on the global endoscopic retrograde cholangiopancreatography market share. The global market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.58% during 2025-2033.

Factors Affecting the Growth of the Endoscopic Retrograde Cholangiopancreatography Industry:

• Increasing Prevalence of Gastrointestinal Diseases:

Whereas the increasing global population is suffering from GI diseases makes the demand for ERCP growing correspondingly. Illnesses, for instance, cholelithiasis, pancreatitis and bile stones are on the Rise due to poor diet, obesity and inadequate physical activity. These diseases entail tricky diagnosis and treatment procedures that are offered by ERCP. Besides this, many other chronic diseases requiring frequent surveillance and management including inflammatory bowel disease (IBD) and chronic pancreatitis where ERCP is very useful.

• Advancements in Technology:

Enhanced visualisation modalities include high definition endoscopy which facilitate better diagnosis of biliary and pancreatic pathologies as well as forward and reverse imaging fluroscopy. Techniques of ERCP such as the minimally invasive (MI) ones enable the patient’s recovery time to be shorter and the risks of complications to be lower than in other procedures, thus client and provider interest is increased. Better designs of stents and various extraction devices also in the field of endoscopy have broadened therapeutic roles of ERCP. Therefore, the process receives help in enhancing the efficiency and security supported by technologies.

• Rising Awareness and Diagnosis Rates:

The growth of public awareness as regards gastrointestinal diseases and the need for early diagnosis is also helping the market to grow. Public and health promotion and the overall availability of health care information has made more patient’s present with gastrointestinal symptoms at an earlier stage. Such an approach leads to early diagnosis of various ailments that can actually be cured or controlled through ERCP. Also, physicians and other healthcare workers are in a better position and more sensitive to prescribe ERCP when initial outpatient tests suggest biliary or pancreatic pathology.

Grab a sample PDF of this report: https://www.imarcgroup.com/endoscopic-retrograde-cholangiopancreatography-market/requestsample

Leading Companies Operating in the Endoscopic Retrograde Cholangiopancreatography Industry:

• Boston Scientific Corporation
• CONMED Corporation
• Cook Group Incorporated
• Fujifilm Holdings Corporation
• Hobbs Medical Inc.
• Johnson & Johnson
• Medi-Globe GmbH
• Medtronic plc
• Olympus Corporation
• Shaili Endoscopy
• Steris Corporation and Telemed Systems Inc.

Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation:

By Product:

• Endoscope
• Endotherapy Devices
• Sphincterotomes
• Lithotripter
• Stents
• Visualization Systems
• Energy Devices
• Others

Endotherapy devices represent the largest segment as they are crucial for both diagnostic and therapeutic purposes.

By Procedure:

• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Sphincterotomy
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation

Biliary sphincterotomy holds the biggest market share due to the rising prevalence of biliary conditions among individuals.

By End User:

• Hospitals and Clinics
• Ambulatory Surgery Centers
• Others

Hospitals and clinics account for the largest market share, driven by their ability to provide comprehensive healthcare services.

Regional Insights:

• North America (the United States and Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)
• Europe (Germany, France, the United Kingdom, Italy, Spain, and others)
• Latin America (Brazil, Mexico, and others)
• Middle East and Africa.

North America enjoys a leading position in the endoscopic retrograde cholangiopancreatography market on account of the presence of highly developed healthcare infrastructure.

Global Endoscopic Retrograde Cholangiopancreatography Market Trends:

Age-related conditions such as gallstones, pancreatic cancer, and biliary strictures are common in the elderly, requiring frequent diagnostic and therapeutic interventions. Older people often require comprehensive and less invasive treatment options, making ERCP a preferred option because of its ability to combine diagnosis and treatment in a single procedure.

Collaborations between key market players, healthcare providers, and research institutions are driving the development of new products and technologies. In addition, ERCP is increasingly being used for therapeutic purposes, such as stent placement, stone removal, and tissue sampling, contributing to market growth. It can perform combined diagnostic and therapeutic procedures in a single session.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145